Yahoo Finance
(NASDAQ:GILD) has reached an agreement with the Pan American Health Organization (PAHO) to expand access to its twice-yearly HIV-prevention drug lenacapavir across Latin America and the Caribbean.
The agreement creates a regional procurement pathway through PAHO for 14 countries, including Brazil, Mexico, Argentina, Colombia and Peru, that were outside Gilead's existing voluntary generic-licensing arrangements.
Availability will still depend on individual countries' regulatory approvals and decisions to adopt the drug.
Reuters notes that new HIV infections in Latin America and the Caribbean increased 13% between 2010 and 2024, highlighting a sizeable unmet prevention need.
Gilead expects lenacapavir to generate about $1 billion in 2026 sales.
The agreement could broaden lenacapavir's commercial footprint while strengthening the drug's position as Gilead Sciences, Inc.
(NASDAQ:GILD)'s next major HIV growth driver.
Gilead reported 12% year-over-year HIV sales growth in Q2 2026, while Yeztugo sales reached $232 million, above the $210 million analyst estimate, reinforcing management's confidence in achieving approximately $1 billion of full-year sales.
Gilead subsequently raised its expected 2026 HIV-product sales growth to 9%-10%.
The PAHO arrangement adds 14 markets to the access pathway and could provide a more coordinated route to government-funded procurement than country-by-country commercialization.
That matters because Latin America has both rising HIV incidence and significant gaps in PrEP utilization.
The agreement also strengthens Gilead's competitive position around long-acting HIV prevention.
| Product | Price | Change |
|---|---|---|
| Brent Crude | $102.14/bbl | +0.34% |
| WTI Crude | $96.90/bbl | +0.21% |
| EN590 Diesel | $846/MT | +0.18% |
| Jet Fuel A-1 | $1090/MT | +0.55% |
| Mazut M100 | $450/MT | -0.15% |
| Bitumen 60/70 | $470/MT | +0.08% |
| Sulphur Gran 99.5% | $470/MT | -0.44% |
| Urea 46% Gran | $650/MT | +1.12% |
| NPK 16-16-16 | $460/MT | -0.28% |
| Nat Gas TTF | $15.42/MMBtu | +0.92% |
Comments
Post a Comment